A comparative study of the discontinuation times for a 6 month period amongst  3 antidepressants found no significant difference.

Team@CMHF

Aim: This study compared the discontinuation time among the three second-generation antidepressants (paroxetine, venlafaxine, and mirtazapine) in a naturalistic setting for outpatient treatment of depression.

Methods: This study used data from retrospectively reviewed medical records of patients admitted to an outpatient psychiatric clinic between January 2003 and December 2005. Patient groups (paroxetine-, venlafaxine-, and mirtazapine-treated) were compared with each other with regard to their discontinuation times for a 6-month period after treatment initiation. The data were analyzed, using a Kaplan-Meier survival analysis, and a Cox proportional hazards regression model.

Results: There were no significant differences in discontinuation times among the three second-generation antidepressants during the 6-month period after initiation of drug therapy.

Conclusions: In a naturalistic setting for the care of depression, it seems that there are no differences in discontinuation times among these three second-generation antidepressants.

Ref: http://www.docguide.com/time-discontinuation-among-three-second-generation-antidepressants-naturalistic-outpatient-setting-d?hash=80445d1a&eid=24262&alrhash=2efbb8-880279c42369cc2f8adcb48a6daaf3d2